Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo
European Journal of PharmacologyPublished 1 November 1978
Ray W. Fuller, Harold D. Snoody, Norman R. Mason, Bryan B. Molloy
Citations59
SJR quartileQ1
SJR score1.20
SNIP0.98
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
All of the results are compatible with the idea that 1-(m-trifluoromethylphenyl)-piperazine acts as a serotonin receptor agonist in rat brain.
Abstract
1-(m-Trifluoromethylphenyl)-piperazine inhibited the specific binding of tritiated serotonin to membranes from rat brain in vitro at lower concentrations than did quipazine or MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine). In rats 1-(m-trifluoromethylphenyl)-piperazine decreased the concentration of 5-hydroxyindoleacetic acid (5-HIAA) without altering the concentration of serotonin in whole brain. The decrease in 5-HIAA was apparently due to a decrease in serotonin turnover, since 1-(m-trifluoromethylphenyl)-piperazine caused a slower decline in serotonin concentration after synthesis inhibition by alpha-propyldopacetamide and a slower accumulation of 5-HIAA after probenecid injection to block its efflux from brain. The decrease in serotonin turnover is an expected result of stimulating serotonin receptors in brain and has earlier been reported to occur with quipazine. Thus all of the results are compatible with the idea that 1-(m-trifluoromethylphenyl)-piperazine acts as a serotonin receptor agonist in rat brain.
Keywords
MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Molecular PharmacologySerotonin and Lysergic Acid Diethylamide Binding in Rat Brain Membranes: Relationship to Postsynaptic Serotonin Receptors
508 Citations1976James P. Bennett, Solomon H. Snyder
The ontogeny of 5- HT and LSD binding sites is nearly identical and does not appear to depend on functionally intact presynaptic 5-HT neuronal input.
Biochemical PharmacologyComparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid
356 Citations1970Francis P. Miller, Raymond H. Cox +2 more
The time-course of effects of a single dose of p -chlorophenylanine on rat brain amines shows a significant lowering of serotonin (5HT) and 5-hydroxyindole-3-acetic acid (5HIAA) beginning on day 1 and lasting for about 8 days.
Journal of Pharmacology and Experimental TherapeuticsSTUDIES ON SYMPATHOMIMETIC AMINES. II. THE BIOTRANS-FORMATION AND PHYSIOLOGICAL DISPOSITION OF D-AM-PHETAMINE, D-P-HYDROXYAMPHETAMINE AND D-METH-AMPHETAMINE
265 Citations1954Julius Axelrod
d-Amphetamine disappears slowly in the dog compared to its hydroxylated derivative, suggesting that in this species the major part of the pharmacological effect of the drug is due to the parent compound.
British Journal of PharmacologyInhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by <scp>l</scp>‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor
179 Citations1971A. David Smith
The hyperactivity and hyperpyrexia produced by l‐tryptophan in rats treated with a monoamine oxidase inhibitor was inhibited by chlorpromazine, and Pretreatment of rats with p‐chlorophenylalanine did not inhibit hyperactivity produced by 5‐MeODMT.
PubMedInhibition of serotonin reuptake.
158 Citations1977Ray W. Fuller, David T. Wong
Through the use of fluoxetine and other serotonin uptake inhibitors, the role of serotonin neurons in various brain functions--behavior, sleep, regulation of pituitary hormone release, thermoregulation, pain responsiveness, and so on--can be studied.
European Journal of PharmacologySerotonin-like actions of quipazine on the central nervous system
127 Citations1973Rodolfo Rodríguez, J.A. Rojas-Ramírez +1 more
Evidence presented in this study suggests that the central actions of quipazine may be due to activation of serotonergic processes, which is similar to those induced by the serotonin precursor.
NeuropharmacologyQuipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour
120 Citations1976A.R. Green, Moussa B. H. Youdim +1 more
Quipazine is a 5-hydroxytryptamine agonist with weak reversible MAO inhibitory action and dopamine is metabolised by both forms of the enzyme, which suggests that it is predominantly a type A MAO inhibitor.
Molecular PharmacologyHigh-Affinity Binding of [3H]5-Hydroxytryptamine to Brain Synaptosomal Membranes: Comparison with [3H]Lysergic Acid Diethylamide Binding
119 Citations1978G. Fillion, Jean-Claude Rousselle +5 more
The interaction between LSD and 5- HT shows that high-affinity binding sites for 5-HT are not identical with those for LSD, since the inhibition of binding of one substance by the other is complex.
Naunyn-Schmiedeberg s Archives of PharmacologyThe effects of quipazine on 5-HT metabolism in the rat brain
99 Citations1976M. Hamon, S. Bourgoin +5 more
Injected in vivo in a dose which affected 5-HT uptake and release, quipazine did not modify MAO activity, however, this activity was noncompetitively inhibited by high concentration of the drug in vitro (Ki=3.0×10−5 M).
Biochemical PharmacologyImportance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramine
94 Citations1978Ray W. Fuller, Harold D. Snoddy +3 more
Comparison of uptake inhibitors as antagonists of PCA is strongly influenced by the pharmacokinetics of the drugs involved.
Life SciencesThe effects of quipazine on serotonin metabolism in rat brain
71 Citations1976Ray W. Fuller, Harold D. Snoddy +5 more
Quipazine reversibly inhibited the oxidation of serotonin by rat brain monoamine oxidase invitro and protected against the irreversible inactivation of the enzyme invivo, but did not prevent the depletion of brain serotonin by p-chloroamphetamine invivo.
Pharmacology Biochemistry and BehaviorQuipazine-induced head-twitch in mice
67 Citations1977Jeffrey B. Malick, Eleanor Doren +1 more
The present studies suggest that quipazine influences serotonin receptors in the brain to produce head-twitch by two mechanisms of action: by direct serotonin receptor activation, and indirectly by causing a release of endogenous serotonin.
NeuropharmacologyMechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism
60 Citations1976Jacob H. Jacoby, Robert A. Howd +2 more
The effects of quipazine on brain serotonin and 5-hydroxyindoleacetic acid concentrations could have been caused by direct activation of central serotonin receptors (which would secondarily decrease impulse flow along serotonergic neurones), or by the inhibition of serotonin reuptake, or by both mechanisms.
Biochemical PharmacologyThe influence of quipazine on the turnover rate of serotonin
50 Citations1974M Grabowska, L Antkiewicz +1 more
European Journal of PharmacologyCentral serotonin-like activity of 6-chloro-2-[1-piperazinyl]-pyrazine (CPP; MK-212)
45 Citations1977Bradley V. Clineschmidt, Jodie C. McGuffin +1 more
Findings indicate that CPP has a serotoninmimetic action in the central nervous system, similar to that produced by pargyline plus tryptophan or other treatments effecting increased activation of central serotonin receptors.
Journal of Pharmacology and Experimental TherapeuticsSYMPATHOMIMETIC PROPERTIES OF CHLORPHENTERMINE: METABOLISM, METABOLIC EFFECTS, INTERACTION WITH RESERPINE AND BIOGENIC AMINES
28 Citations1963Bernard Dubnick, Gerald A. Leeson +3 more
Comparison of rates of metabolism and lipid/aqueous distribution ratios of chlor phentermine and several closely related compounds suggested that the prolonged pharmacological effects of chlorphentermine may be attributable to the influence of the para -chlorine.